5q- syndrome
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
3180-3183
Author(s):
Jacqueline Boultwood, Andrea Pellagatti and James S. Wainscoat
Immunosuppressive Therapy for Myelodysplastic Syndromes
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
3184-3189
Author(s):
Christiane Dobbelstein and Arnold Ganser
Pathophysiological and Clinical Aspects of Iron Chelation Therapy in MDS
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
3222-3234
Author(s):
Norbert Gattermann
Biomarkers of Protein Oxidation in Human Disease
Journal:
Current Molecular Medicine
Volume:
12
Page:
681-697
Author(s):
A. Garcia-Garcia, H. Rodriguez-Rocha, N. Madayiputhiya, A. Pappa, M. I. Panayiotidis and R. Franco
Application of Artificial Neural Networks for the Prediction of Antitumor Activity of a Series of Acridinone Derivatives
Journal:
Medicinal Chemistry
Volume:
8
Page:
309-319
Author(s):
Marcin Koba
Synthesis and β-Glucuronidase Inhibitory Potential of Benzimidazole Derivatives
Journal:
Medicinal Chemistry
Volume:
8
Page:
421-427
Author(s):
Khalid Mohammed Khan, Momin Khan, Nida Ambreen, Fazal Rahim, Shagufta Naureen, Shahnaz Perveen, M. Iqbal Choudhary and Wolfgang Voelter
Emerging Roles for Modulation of microRNA Signatures in Cancer Chemoprevention
Journal:
Current Cancer Drug Targets
Volume:
12
Page:
716-740
Author(s):
K. Neelakandan, P. Babu and S. Nair
Pharma-metabolomics in Neonatology: is it a Dream or a Fact?
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
2996-3006
Author(s):
Vassilios Fanos, Luigi Barberini, Roberto Antonucci and Luigi Atzori
The Tachykinergic System as Avenues for Drug Intervention
Journal:
Recent Patents on CNS Drug Discovery (Discontinued)
Volume:
7
Page:
173-180
Author(s):
Pranela Rameshwar
New Directions in Targeting Protein Kinases: Focusing Upon True Allosteric and Bivalent Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
2936-2945
Author(s):
Vandana Lamba and Indraneel Ghosh